Cumberland Pharmaceuticals (CPIX) Treasury Shares (2011 - 2025)
Cumberland Pharmaceuticals (CPIX) reported Treasury Shares of $7170.0 for Q2 2025, down 94.34% on a YoY basis from $126689.0 in Q2 2024, and down 97.06% sequentially from $243705.0 in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Treasury Shares (2011 - 2025) Analysis & Trends
Cumberland Pharmaceuticals (CPIX) has 9 years of Treasury Shares data on file, last reported at $7170.0 in Q2 2025.
- For the quarter ending Q2 2025, Treasury Shares fell 94.34% year-over-year to $7170.0; the trailing twelve-month figure through Jun 2025 stood at $7170.0 (down 94.34% YoY), and the FY2019 full-year result was $3.5 million, up 21.16% from the prior year.
- Treasury Shares slipped to $7170.0 in Q2 2025, from $243705.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $568181.0 in Q4 2021 to a low of $112585.0 in Q4 2025.
- A 5-year average of $295381.6 and a median of $260566.0 in 2023 frame the typical range for Treasury Shares.
- Across the five-year window, Treasury Shares soared 155.4% in 2023 and sank 94.34% in 2025, its largest moves.
- Tracing CPIX's Treasury Shares over 5 years: stood at $1.0 million in 2021, then sank by 92.12% to $78793.0 in 2022, then soared by 155.4% to $201237.0 in 2023, then surged by 148.46% to $500000.0 in 2024, then sank by 98.57% to $7170.0 in 2025.
- Business Quant data shows CPIX's Treasury Shares at $7170.0 in Q2 2025, $243705.0 in Q1 2025, and $500000.0 in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 62.52 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 107.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.29 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 313.27 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.44 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Cumberland Pharmaceuticals | 104.57 Mn | 93.23 Mn | 7.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 112,585.00 |
| Dec 31, 2025 | 112,585.00 |
| Jun 30, 2025 | 7,170.00 |
| Jun 30, 2025 | 7,170.00 |
| Mar 31, 2025 | 243,705.00 |
| Mar 31, 2025 | 243,705.00 |
| Dec 31, 2024 | 139,825.00 |
| Dec 31, 2024 | 139,825.00 |
| Sep 30, 2024 | 500,000.00 |
| Sep 30, 2024 | 500,000.00 |
| Jun 30, 2024 | 126,689.00 |
| Jun 30, 2024 | 126,689.00 |
| Mar 31, 2024 | 246,599.00 |
| Mar 31, 2024 | 246,599.00 |
| Dec 31, 2023 | 260,566.00 |
| Dec 31, 2023 | 260,566.00 |
| Sep 30, 2023 | 201,237.00 |
| Sep 30, 2023 | 201,237.00 |
| Jun 30, 2023 | 171,616.00 |
| Jun 30, 2023 | 171,616.00 |